Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Stievamycin Regular Gel (Tretinoin 0.025% Erythromycin 4%) 45g (September 27, 2012)
- Starting date:
- September 27, 2012
- Posting date:
- October 15, 2012
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-26255
Reason
Lot L1651 of Stievamycin Regular Gel 45g has been found to have concentrations of Tretinoin that are lower than the label claim of 0.025% for this ingredient.
Depth of distribution
Wholesalers and Pharmacies
Affected products
Stievamycin Regular Gel (Tretinoin 0.025% Erythromycin 4%) 45g
DIN, NPN, DIN-HIM
DIN 01905112
Dosage form
Topical Gel
Strength
- Tretinoin 0.025%
- Erythromycin 4%
Lot or serial number
L1651
Companies
- Recalling Firm
- GlaxoSmithKline Inc.
7333 Mississauga Road
Mississauga Ontario
Canada L5N 6L4
- Marketing Authorization Holder
- GlaxoSmithKline Inc.
7333 Mississauga Road
Mississauga Ontario
Canada L5N 6L4
- Date modified: